Published in Obesity (Silver Spring) on November 01, 2006
Gender differences in insulin resistance, body composition, and energy balance. Gend Med (2009) 3.19
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr (2008) 2.55
Treating prediabetes with metformin: systematic review and meta-analysis. Can Fam Physician (2009) 2.18
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev (2011) 2.01
Expected changes in clinical measures of adiposity during puberty. J Adolesc Health (2010) 1.53
Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes (2007) 1.45
Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care (2011) 1.36
Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women. Diabetologia (2010) 1.15
Metformin pharmacogenomics: current status and future directions. Diabetes (2014) 1.15
Birth cohort effects on abdominal obesity in the United States: the Silent Generation, Baby Boomers and Generation X. Int J Obes (Lond) (2012) 1.06
Perceived weight discrimination amplifies the link between central adiposity and nondiabetic glycemic control (HbA1c). Ann Behav Med (2011) 1.04
Risk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain, a Mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort study. BMC Endocr Disord (2013) 0.87
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs (2015) 0.86
Identifying obesity indicators which best correlate with type 2 diabetes in a Chinese population. BMC Public Health (2012) 0.82
Prevention of Diabetes Through the Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to Practice. Curr Nutr Rep (2014) 0.81
Genetic Predisposition to Central Obesity and Risk of Type 2 Diabetes: Two Independent Cohort Studies. Diabetes Care (2015) 0.81
Anthropometric variables accurately predict dual energy x-ray absorptiometric-derived body composition and can be used to screen for diabetes. PLoS One (2011) 0.81
Obesity attenuates gender differences in cardiovascular mortality. Cardiovasc Diabetol (2014) 0.81
Meat consumption as a risk factor for type 2 diabetes. Nutrients (2014) 0.80
Impaired glucose tolerance and obesity as effect modifiers of ethnic disparities of the progression to diabetes: the San Antonio Heart Study. Diabetes Care (2012) 0.79
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance. Diabetes Obes Metab (2013) 0.79
Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants. Diabetes (2015) 0.77
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res (1998) 50.73
The disease burden associated with overweight and obesity. JAMA (1999) 19.39
The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care (1999) 16.79
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med (2004) 11.46
The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. Diabetes Care (2000) 10.08
Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr (2004) 8.87
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med (2001) 7.07
Waist circumference as a measure for indicating need for weight management. BMJ (1995) 7.01
Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67
The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med (2005) 5.76
Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res (2004) 5.74
Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab (1982) 5.60
Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care (2000) 4.64
Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes (1997) 4.15
The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr (1956) 4.11
Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest (1995) 3.44
Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism (1987) 3.32
Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol (1997) 3.32
Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism (2001) 3.25
Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol (2000) 3.01
Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. Am J Epidemiol (1981) 2.97
Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr (1999) 2.79
Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab (2000) 2.54
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes (2005) 2.46
Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism (1996) 2.38
Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes (1997) 2.26
The health consequences of moderate obesity. Int J Obes (1981) 2.21
Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care (1999) 2.20
Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes (1990) 2.15
Visceral adipose tissue differences in black and white women. Am J Clin Nutr (1995) 2.07
A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr (1996) 2.04
Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes (1989) 1.96
Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. J Clin Epidemiol (1991) 1.74
Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. Diabetes Care (2003) 1.44
Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev Med (1983) 1.41
Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables. J Appl Physiol (1985) (2000) 1.39
Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes (1986) 1.32
Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes (1990) 1.27
The association of lifetime weight and weight control patterns with diabetes among men and women in an adult community. Int J Obes (1989) 1.21
Abdominal adiposity values associated with established body mass indexes in white, black and hispanic Americans. A study from the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord (2000) 1.19
Don't throw the baby out with the bath water. Am J Clin Nutr (2004) 1.18
Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women. Diabetes Care (1996) 1.16
Insulin sensitivity and serum triglyceride level in obese white and black women: relationship to visceral and truncal subcutaneous fat. Metabolism (1999) 1.10
Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes (1995) 1.03
Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes (1989) 0.96
Difference in diabetic and nondiabetic fat distribution patterns by skinfold measurements. Diabetes (1969) 0.96